Analystreport

Biohaven Ltd. (NYSE: BHVN) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $59.00 price target on the stock.

Biohaven Ltd. Common Shares  (BHVN) 
Last biohaven ltd. common shares earnings: 2/25 04:45 pm Check Earnings Report
US:NYSE Investor Relations: investors.biohavenpharma.com